Anti-tumor effects of (1→3)-β-d-glucan from Saccharomyces cerevisiae in S180 tumor-bearing mice

Int J Biol Macromol. 2017 Feb:95:385-392. doi: 10.1016/j.ijbiomac.2016.10.106. Epub 2016 Nov 9.

Abstract

(1→3)-β-d-Glucan from Saccharomyces cerevisiae is a typical polysaccharide with various biological effects and is considered a candidate for the prevention and treatment of cancer in vitro. Research into the function of (1→3)-β-d-glucan in tumor-bearing animals in vivo, however, is limited. Here, we investigated the effects of (1→3)-β-d-glucan from S. cerevisiae on S180 tumor-bearing mice and on the immunity of the tumor-bearing host. The molecular mechanisms underlying the observed effects were investigated. (1→3)-β-d-Glucan was shown to exert anti-tumor effects without toxicity in normal mouse cells. The volume and weight of S180 tumors decreased dramatically following treatment with (1→3)-β-d-glucan, and treatment with the polysaccharide was furthermore shown to increase the tumor inhibition rate in a dose-dependent manner. Spleen index, T lymphocyte subsets (CD4 and CD8), as well as interleukins (IL)-2, (IL-2, IL-6), and tumor necrosis factor-α were assayed to detect the immunoregulatory and anti-tumor effects after (1→3)-β-d-glucan intragastrical administration. (1→3)-β-d-Glucan was shown to significantly potentiate the mouse immune responses by, among other effects, decreasing the ratio of CD4 to CD8. The expression levels of IL-2, IL-6, and TNF-α were also significantly increased by (1→3)-β-d-glucan. These results suggest that (1→3)-β-d-glucan enhances the host's immune function during the tumor inhibition process. S180 tumor cells treated with (1→3)-β-d-glucan also exhibited significant apoptotic characteristics. (1→3)-β-d-glucan increased the ratio of Bax to Bcl-2 at the translation level by up-regulating Bax expression and down-regulating Bcl-2 expression, resulting in the initiation of cell apoptosis in S180 tumor-bearing mice. Taken together, these results indicate that the anti-tumor effects exerted by (1→3)-β-d-glucan may be attributed to the polysaccharide's immunostimulating properties and apoptosis-inducing features. Further investigation into these properties and their associated mechanisms will contribute to the development of potent polysaccharide-based anti-tumor agents.

Keywords: (1→3)-β-d-Glucan; Anti-tumor; Apoptosis; Immunomodulatory; S180-bearing mice.

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • CD4 Antigens / blood
  • CD8 Antigens / blood
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Cytokines / blood
  • Male
  • Mice
  • Proteoglycans
  • Saccharomyces cerevisiae / chemistry*
  • Spleen / drug effects
  • Spleen / immunology
  • Tumor Burden / drug effects
  • Xenograft Model Antitumor Assays
  • beta-Glucans / pharmacology*

Substances

  • Antineoplastic Agents
  • CD4 Antigens
  • CD8 Antigens
  • Cytokines
  • Proteoglycans
  • beta-Glucans
  • polysaccharide-K